Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2014, Issue 1, Pages 8-13
Publisher
American Society of Hematology
Online
2014-11-25
DOI
10.1182/asheducation-2014.1.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
- (2014) L. S. Muffly et al. HAEMATOLOGICA
- Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
- (2013) H. D. Klepin et al. BLOOD
- Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study
- (2013) Anjali Shah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcome of older patients with acute myeloid leukemia
- (2013) Mya S. Thein et al. CANCER
- Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification
- (2013) M. Wetzler et al. HAEMATOLOGICA
- Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
- (2013) Alexander E. Sherman et al. LEUKEMIA RESEARCH
- Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
- (2012) B. Deschler et al. HAEMATOLOGICA
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia
- (2012) Irena Djunic et al. Hematology
- Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer
- (2012) Pierre Soubeyran et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia
- (2012) H. Mohamedali et al. LEUKEMIA RESEARCH
- Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
- (2011) Martine Extermann et al. CANCER
- Gait Speed and Survival in Older Adults
- (2011) Stephanie Studenski JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
- (2011) Arti Hurria et al. JOURNAL OF CLINICAL ONCOLOGY
- Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
- (2011) Arti Hurria et al. JOURNAL OF CLINICAL ONCOLOGY
- The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia
- (2011) Heidi D. Klepin et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
- (2010) H. Kantarjian et al. BLOOD
- A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
- (2010) C. Rollig et al. BLOOD
- Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
- (2010) Utz Krug et al. LANCET
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials
- (2009) Keith Wheatley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treating octogenarian and nonagenarian acute myeloid leukemia patients-Predictive prognostic models
- (2009) Antoine J. Harb et al. CANCER
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
- Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia
- (2008) Shabbir M.H. Alibhai et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia
- (2008) J.-V. Malfuson et al. HAEMATOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation